We have previously shown that SAM treatment causes hypermethylation of urokinase type plasminogen activator (uPA) in breast cancer cells and the knock down of methyl DNA-binding protein 2 resulting in silencing of the uPA gene by reverting the hypomethylated state of this gene in breast and prostate cancer cells 24,25. Here, PLAU is linked to Familial prostate cancer.